NYSE:COO - Cooper Companies Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started $248.8350 -1.13 (-0.45 %) (As of 12/17/2018 12:31 PM ET)Previous Close$249.97Today's Range$241.81 - $249.8252-Week Range$216.47 - $283.18Volume163,415 shsAverage Volume421,131 shsMarket Capitalization$12.28 billionP/E Ratio21.64Dividend Yield0.02%Beta0.76 ProfileDiscussionAnalyst RatingsChartDividendEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email The Cooper Companies, Inc. operates as a medical device company worldwide. It operates through CooperVision and CooperSurgical business units. The company develops, manufactures, and markets a range of contact lenses, including spherical lenses, and toric and multifocal lenses that correct near- and farsightedness, as well as addresses various complex visual defects, such as astigmatism and presbyopia. It also provides range of products and services focusing on women's health, including medical devices, fertility, genomics, and diagnostics and contraception for hospitals and surgical centers, obstetricians' and gynecologists' (ob/gyns) medical offices, and fertility clinics. In addition, the company offers carrier screening, preimplantation genetic screening, and preimplantation genetic diagnosis used in IVF process; IVF medical devices, systems, and equipment; and PARAGARD, a non-hormonal, copper intrauterine device for birth control. Further, The Cooper Companies, Inc. offers its products under Biofinity, clarity 1day, MyDay, and Proclear 1 Day brand name. The company markets its products through a network of field sales representatives, independent agents, and distributors. The Cooper Companies, Inc. was founded in 1980 and is headquartered in Pleasanton, California. Receive COO News and Ratings via Email Sign-up to receive the latest news and ratings for COO and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange NYSE Industry Ophthalmic goods Sub-IndustryHealth Care Supplies SectorMedical Current SymbolNYSE:COO Previous Symbol CUSIP21664840 Webwww.coopercos.com Phone925-460-3600 Debt Debt-to-Equity Ratio0.60 Current Ratio2.03 Quick Ratio1.16 Price-To-Earnings Trailing P/E Ratio21.64 Forward P/E Ratio21.60 P/E Growth2.02 Sales & Book Value Annual Sales$2.53 billion Price / Sales4.83 Cash Flow$14.5518 per share Price / Cash Flow17.10 Book Value$67.31 per share Price / Book3.70 Profitability EPS (Most Recent Fiscal Year)$11.50 Net Income$139.90 million Net Margins5.52% Return on Equity17.70% Return on Assets9.10% Miscellaneous Employees11,800 Outstanding Shares49,140,000Market Cap$12.28 billion OptionableOptionable Cooper Companies (NYSE:COO) Frequently Asked Questions What is Cooper Companies' stock symbol? Cooper Companies trades on the New York Stock Exchange (NYSE) under the ticker symbol "COO." How often does Cooper Companies pay dividends? What is the dividend yield for Cooper Companies? Cooper Companies announced a semiannual dividend on Friday, July 13th. Investors of record on Monday, July 23rd will be given a dividend of $0.03 per share on Tuesday, August 7th. This represents a yield of 0.02%. The ex-dividend date is Friday, July 20th. View Cooper Companies' Dividend History. How will Cooper Companies' stock buyback program work? Cooper Companies announced that its Board of Directors has authorized a stock buyback program on Friday, April 7th 2017, which authorizes the company to repurchase $500,000,000.00 in shares, according to EventVestor. This repurchase authorization authorizes the company to repurchase up to 5.2% of its shares through open market purchases. Shares repurchase programs are often an indication that the company's board believes its stock is undervalued. How were Cooper Companies' earnings last quarter? Cooper Companies Inc (NYSE:COO) released its quarterly earnings results on Thursday, December, 6th. The medical device company reported $2.87 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $2.96 by $0.09. The medical device company earned $651.50 million during the quarter, compared to analysts' expectations of $645.25 million. Cooper Companies had a net margin of 5.52% and a return on equity of 17.70%. The business's quarterly revenue was up 16.0% on a year-over-year basis. During the same period in the previous year, the firm earned $2.65 EPS. View Cooper Companies' Earnings History. When is Cooper Companies' next earnings date? Cooper Companies is scheduled to release their next quarterly earnings announcement on Thursday, March 14th 2019. View Earnings Estimates for Cooper Companies. What guidance has Cooper Companies issued on next quarter's earnings? Cooper Companies issued an update on its FY19 earnings guidance on Thursday, December, 6th. The company provided earnings per share (EPS) guidance of $11.30-11.70 for the period, compared to the Thomson Reuters consensus estimate of $12.08. The company issued revenue guidance of $2.60-2.66 billion, compared to the consensus revenue estimate of $2.67 billion.Cooper Companies also updated its FY 2019 guidance to $11.30-11.70 EPS. What price target have analysts set for COO? 9 analysts have issued 1 year price targets for Cooper Companies' stock. Their forecasts range from $231.00 to $306.00. On average, they anticipate Cooper Companies' share price to reach $286.8750 in the next year. This suggests a possible upside of 15.3% from the stock's current price. View Analyst Price Targets for Cooper Companies. What is the consensus analysts' recommendation for Cooper Companies? 9 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Cooper Companies in the last year. There are currently 4 hold ratings and 5 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Cooper Companies. Has Cooper Companies been receiving favorable news coverage? Press coverage about COO stock has trended somewhat positive recently, according to InfoTrie Sentiment. The research firm identifies negative and positive news coverage by analyzing more than six thousand blog and news sources. The firm ranks coverage of public companies on a scale of negative five to five, with scores closest to five being the most favorable. Cooper Companies earned a news sentiment score of 1.0 on InfoTrie's scale. They also assigned media headlines about the medical device company a news buzz of 4.0 out of 10, meaning that recent news coverage is somewhat unlikely to have an impact on the stock's share price in the next several days. Who are some of Cooper Companies' key competitors? Some companies that are related to Cooper Companies include Illumina (ILMN), Celgene (CELG), HCA Healthcare (HCA), Vertex Pharmaceuticals (VRTX), Zoetis (ZTS), Regeneron Pharmaceuticals (REGN), Humana (HUM), Baxter International (BAX), Edwards Lifesciences (EW), Actelion (ALIOF), ASTELLAS PHARMA/ADR (ALPMY), ESSILOR Intl S/S (ESLOY), Takeda Pharmaceutical (TKPYY), FRESENIUS SE &/S (FSNUY) and Centene (CNC). Who are Cooper Companies' key executives? Cooper Companies' management team includes the folowing people: Mr. Albert G. White III, Pres, CEO & Director (Age 48)Mr. Daniel G. McBride Esq., Chief Operating Officer, Exec. VP and Pres of CooperVision Inc (Age 54)Mr. Agostino Ricupati, Sr. VP of Fin. & Tax and Chief Accounting OfficerMs. Carol R. Kaufmann, Advisor (Age 69)Mr. Brian Andrews, Sr. VP, CFO & Treasurer Who are Cooper Companies' major shareholders? Cooper Companies' stock is owned by a number of of retail and institutional investors. Top institutional investors include Vanguard Group Inc (10.26%), BlackRock Inc. (7.10%), Massachusetts Financial Services Co. MA (5.68%), Janus Henderson Group PLC (5.33%), Frontier Capital Management Co. LLC (1.91%) and FIL Ltd (1.66%). Company insiders that own Cooper Companies stock include A Thomas Bender, Agostino Ricupati, Allan E Rubenstein, Carol R Kaufman, Daniel G Mcbride, Gary S Petersmeyer, Jody S Lindell, Michael Kalkstein, Paul L Remmell, Randal Golden, Robert S Weiss and Stanley Md Zinberg. View Institutional Ownership Trends for Cooper Companies. Which institutional investors are selling Cooper Companies stock? COO stock was sold by a variety of institutional investors in the last quarter, including Panagora Asset Management Inc., Massachusetts Financial Services Co. MA, BlackRock Inc., AXA, JPMorgan Chase & Co., JPMorgan Chase & Co., Martingale Asset Management L P and Los Angeles Capital Management & Equity Research Inc.. Company insiders that have sold Cooper Companies company stock in the last year include A Thomas Bender, Agostino Ricupati, Allan E Rubenstein, Carol R Kaufman, Daniel G Mcbride, Gary S Petersmeyer, Michael Kalkstein, Randal Golden, Robert S Weiss and Stanley Md Zinberg. View Insider Buying and Selling for Cooper Companies. Which institutional investors are buying Cooper Companies stock? COO stock was acquired by a variety of institutional investors in the last quarter, including Findlay Park Partners LLP, Putnam Investments LLC, Federated Investors Inc. PA, Morgan Stanley, Marshall Wace North America L.P., Kornitzer Capital Management Inc. KS, FIL Ltd and Frontier Capital Management Co. LLC. View Insider Buying and Selling for Cooper Companies. How do I buy shares of Cooper Companies? Shares of COO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is Cooper Companies' stock price today? One share of COO stock can currently be purchased for approximately $248.86. How big of a company is Cooper Companies? Cooper Companies has a market capitalization of $12.28 billion and generates $2.53 billion in revenue each year. The medical device company earns $139.90 million in net income (profit) each year or $11.50 on an earnings per share basis. Cooper Companies employs 11,800 workers across the globe. What is Cooper Companies' official website? The official website for Cooper Companies is http://www.coopercos.com. How can I contact Cooper Companies? Cooper Companies' mailing address is 6140 Stoneridge Mall Road Suite 590, PLEASANTON CA, 94588. The medical device company can be reached via phone at 925-460-3600 or via email at [email protected] MarketBeat Community Rating for Cooper Companies (NYSE COO)Community Ranking: 2.6 out of 5 ( )Outperform Votes: 429 (Vote Outperform)Underperform Votes: 383 (Vote Underperform)Total Votes: 812MarketBeat's community ratings are surveys of what our community members think about Cooper Companies and other stocks. Vote "Outperform" if you believe COO will outperform the S&P 500 over the long term. Vote "Underperform" if you believe COO will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 12/17/2018 by MarketBeat.com StaffFeatured Article: What is a conference call?